AS Latvijas Juras medicinas centrs (UOM) — Capital Reinvestment Ratio
Latest as of September 2025:
0.91x
AS Latvijas Juras medicinas centrs (UOM) has a Capital Reinvestment Ratio of 0.91x as of September 2025, meaning it reinvests 1% of its operating cash flow (€474.45K) in capital expenditures (€430.89K). See UOM FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.91x
Capex / Operating Cash Flow
Operating Cash Flow
€474.45K
EUR
Capital Expenditures
€430.89K
EUR
Data as of
Sep 2025
Most recent filing
AS Latvijas Juras medicinas centrs Capital Reinvestment Ratio (2015–2024)
This chart tracks AS Latvijas Juras medicinas centrs's Capital Reinvestment Ratio across 10 annual periods.
Annual Capital Reinvestment Ratio for AS Latvijas Juras medicinas centrs (2015–2024)
Year-by-year Capital Reinvestment Ratio for AS Latvijas Juras medicinas centrs from 2015 to 2024. For live market cap and broader valuation context, see market value of AS Latvijas Juras medicinas centrs.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.72x | €605.02K | €436.21K | ▼ -44.4% |
| 2023 | 1.30x | €1.91 Million | €2.48 Million | ▲ +125.1% |
| 2022 | 0.58x | €1.09 Million | €629.72K | ▼ -78.3% |
| 2021 | 2.65x | €418.24K | €1.11 Million | ▲ +277.5% |
| 2020 | 0.70x | €732.71K | €515.12K | ▲ +52.6% |
| 2019 | 0.46x | €412.86K | €190.16K | ▲ +219.4% |
| 2018 | 0.14x | €599.57K | €86.45K | ▼ -88.6% |
| 2017 | 1.27x | €478.41K | €605.51K | ▼ -38.4% |
| 2016 | 2.06x | €418.49K | €860.13K | ▲ +186.4% |
| 2015 | 0.72x | €362.36K | €260.06K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow